drug-development / pipeline
관점별 · 1 시각 이번 호 전체
FierceBiotech · United States · Isomorphic Labs raises $2.1B to push AI-designed drugs into the clinic
Reports the capital funds the next-generation IsoDDE model and Isomorphic's joint programs with Novartis, Eli Lilly and J&J, including a Lilly deal worth up to $1.7B in milestones, as it races to be the first AI-native firm into Phase 1 from its own pipeline.
“Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model.”